Matinas Biopharma Holdings, Inc. (MTNB) SEC Filings — 2024
18 SEC filings for Matinas Biopharma Holdings, Inc. (MTNB) in 2024.
Filings
- Matinas BioPharma Appoints New Chief Medical Officer — 8-K · Nov 27, 2024
- Matinas BioPharma Files Q3 2024 10-Q Report — 10-Q · Nov 13, 2024
- Matinas BioPharma Reports 8-K Filing with Key Corporate Updates — 8-K · Oct 31, 2024
- Matinas Biopharma Holdings, Inc. SC 13G Filing — SC 13G · Oct 25, 2024
- Matinas BioPharma Announces Executive and Board Changes — 8-K · Oct 24, 2024
- Matinas BioPharma Files 8-K on Security Holder Rights — 8-K · Sep 3, 2024
- Matinas BioPharma to be Acquired by New Mountain Capital — 8-K · Aug 28, 2024
- Matinas BioPharma to be Acquired by 3D Medicines — 8-K · Aug 20, 2024
- Matinas BioPharma Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Matinas BioPharma Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Matinas BioPharma Files 8-K: Material Agreement — 8-K · Apr 5, 2024
- Matinas BioPharma Files 8-K for Disclosure and Exhibits — 8-K · Mar 28, 2024
- Matinas BioPharma Holdings, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024
- Matinas BioPharma Files 8-K — 8-K · Mar 25, 2024
- Matinas BioPharma Files 8-K — 8-K · Mar 22, 2024
- Matinas BioPharma Files Routine 8-K — 8-K · Feb 26, 2024
- Matinas BioPharma Files 8-K on Current Events — 8-K · Feb 20, 2024
- Matinas BioPharma Files 8-K for Reg FD Disclosure on Jan 9, 2024 — 8-K · Jan 9, 2024